Rethinking Resection and Transplant Candidacy for HCC: Should Tumor Biology Replace Size-Based Criteria? Alexandra W. AcherDaniel E. Abbott Hepatobiliary Tumors 14 November 2019 Pages: 1309 - 1311
Deciphering the Molecular Landscape of Appendiceal Mucinous Neoplasms for Diagnostic, Prognostic and Therapeutic Purposes Haroon A. ChoudryDavid L. Bartlett Peritoneal Surface Malignancy 23 January 2020 Pages: 1312 - 1313
Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma Audrey E. KamSam G. PappasAshiq Masood Gastrointestinal Oncology 17 December 2019 Pages: 1314 - 1315
Esophageal Cancer and Surgical Margins: When a Positive Is a Negative Stephanie G. Worrell Thoracic Oncology 03 January 2020 Pages: 1316 - 1317
Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM M. Susan HallbeckKatherine E. LawJudy C. Boughey Health Services Research and Global Oncology Open access 08 January 2020 Pages: 1318 - 1326
ASO Author Reflections: Poor Ergonomics During Surgical Procedures May Lead to Work-Related Pain and Early Retirement M. Susan HallbeckKatherine E. LawJudy C. Boughey ASO Author Reflections 28 February 2020 Pages: 1327 - 1328
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma Dhaval PatelJohn E. PhayLawrence T. Kim Endocrine Tumors 28 February 2020 Pages: 1329 - 1337
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma Dhaval PatelJohn E. PhayCarmen C. Solórzano Endocrine Tumors 28 February 2020 Pages: 1338 - 1347
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? Elettra MerolaAnja RinkeMarianne E. Pavel Endocrine Tumors 12 November 2019 Pages: 1348 - 1355
Lessons Learned from the Transoral Endoscopic Thyroidectomy with Vestibular Approach (TOETVA) for the Treatment of Thyroid Carcinoma Kuauhyama Luna-OrtizAntonio Gómez-PedrazaAngkoon Anuwong Endocrine Tumors 20 November 2019 Pages: 1356 - 1360
Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients Yongcong YanQianlei ZhouZhiyu Xiao Hepatobiliary Tumors 26 November 2019 Pages: 1361 - 1371
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study Jun LiMohamed MoustafaSilvio Nadalin Hepatobiliary Tumors Open access 30 January 2020 Pages: 1372 - 1384
ASO Author Reflections: Optimizing the Oncological Outcome for Locally Advanced Intrahepatic Cholangiocarcinoma Jun LiM. MoustafaA. Heumann ASO Author Reflections Open access 02 March 2020 Pages: 1385 - 1386
How Many Steps Per Day are Necessary to Prevent Postoperative Complications Following Hepato-Pancreato-Biliary Surgeries for Malignancy? Hiroki NakajimaYukihiro YokoyamaMasato Nagino Hepatobiliary Tumors 23 January 2020 Pages: 1387 - 1397
ASO Author Reflections: Please Walk at Least 5000 Steps per Day before Major Hepato-Pancreato-Biliary (HPB) Surgeries for Malignancy Yukihiro YokoyamaHiroki NakajimaMasato Nagino ASO Author Reflections 02 March 2020 Pages: 1398 - 1399
Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes Jon M. HarrisonJennifer Y. WoCarlos Fernandez-del Castillo Hepatobiliary Tumors 22 November 2019 Pages: 1400 - 1406
The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB–IIC Patients—Results After 3 Years Eric A. DeckersJosette E. H. M. Hoekstra-WeebersHarald J. Hoekstra Melanoma Open access 18 September 2019 Pages: 1407 - 1417
ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified Anne Brecht FranckenJosette E. H. M. Hoekstra-WeebersHarald J. Hoekstra ASO Author Reflections Open access 03 September 2019 Pages: 1418 - 1419
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients Jüri TerasHidde M. KroonJohn F. Thompson Melanoma 09 March 2020 Pages: 1420 - 1429
ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective Jüri TerasHidde M. KroonJonathan S. Zager ASO Author Reflections 06 March 2020 Pages: 1430 - 1431
Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma Jennifer J. KwakAdam L. KesnerNicole Kounalakis Melanoma 26 November 2019 Pages: 1432 - 1438
Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Jing SuGuangxu JinEdward A. Levine Peritoneal Surface Malignancy 24 January 2020 Pages: 1439 - 1447
The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis Eliahu BekhorJacquelyn CarrDeepa Magge Peritoneal Surface Malignancy 23 December 2019 Pages: 1448 - 1455
ASO Author Reflections: Major Late Complication Rates are Higher for Patients Who Underwent Iterative CRS\HIPEC When Compared to a Singular Procedure Eliahu BekhorDeepa Magge ASO Author Reflections 02 March 2020 Pages: 1456 - 1457
Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction Aditi BhattOlivier Glehen Peritoneal Surface Malignancy 21 January 2020 Pages: 1458 - 1470
ASO Author Reflections: Tailoring the Extent of Peritoneal Resection for Peritoneal Metastases According to the Primary Tumor Site Aditi BhattOlivier Glehen ASO Author Reflections 11 March 2020 Pages: 1471 - 1472
Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma Eric M. GrohShreya GuptaJeremy L. Davis Gastrointestinal Oncology 20 November 2019 Pages: 1473 - 1479
Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study Zeping HuangYutong ChenYoucheng Zhang Gastrointestinal Oncology 27 November 2019 Pages: 1480 - 1487
Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma Qifeng WangLin PengJinyi Lang Thoracic Oncology 23 January 2020 Pages: 1488 - 1495
Margin Positivity in Resectable Esophageal Cancer: Are there Modifiable Risk Factors? Cary Jo R. SchlickRhami KhorfanDavid J. Bentrem Thoracic Oncology 13 January 2020 Pages: 1496 - 1507
ASO Author Reflections: Margin Positivity Following Esophageal Cancer Resection is Associated with Treatment Decisions Cary Jo R. SchlickDavid J. Bentrem ASO Author Reflections 20 February 2020 Pages: 1508 - 1509
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma Takeshi SuzukiAkihiko OkamuraKeisho Chin Thoracic Oncology 09 December 2019 Pages: 1510 - 1517
ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma? Takeshi SuzukiAkihiko OkamuraKeisho Chin ASO Author Reflections 27 February 2020 Pages: 1518 - 1519
Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study Jorianne BoersAnnalie JoldersmaJan Willem B. de Groot Thoracic Oncology 11 December 2019 Pages: 1520 - 1528
ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer Jorianne BoersJan Willem B. de Groot ASO Author Reflections 28 February 2020 Pages: 1529 - 1529
Esophagectomy for Esophageal Cancer in a Patient with Left Pulmonary Artery Sling Keita TakahashiAkihiko OkamuraMasayuki Watanabe Thoracic Oncology 12 December 2019 Pages: 1530 - 1530
ASO Author Reflections: Cervicothoracoscopic Esophagectomy for Esophageal Cancer Keita TakahashiAkihiko OkamuraMasayuki Watanabe ASO Author Reflections 02 March 2020 Pages: 1531 - 1532
Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon Beth A. HelminkChristina L. RolandJennifer A. Wargo Translational Research and Biomarkers 21 January 2020 Pages: 1533 - 1545
Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma Xiang-Nan YuGuang-Cong ZhangJi-Min Zhu Translational Research and Biomarkers 10 March 2020 Pages: 1546 - 1557
ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma Xiang-Nan YuXi-Zhong ShenJi-Min Zhu ASO Author Reflections 12 March 2020 Pages: 1558 - 1559
Prolonged Length of Stay After Robotic Prostatectomy: Causes and Risk Factors Marshall C. StrotherKatharine F. MichelDavid I. Lee Urologic Oncology 26 February 2020 Pages: 1560 - 1567
ASO Author Reflections: Prolonged Length of Stay After Robotic-Assisted Radical Prostatectomy—A Separate Problem from Perioperative Complications Katharine F. MichelMarshall C. StrotherDavid I. Lee ASO Author Reflections 06 March 2020 Pages: 1568 - 1569
Neoadjuvant Chemoradiotherapy and Tumor Recurrence in Patients with Early T-Stage Cancer of the Lower Rectum Ian P. HayesElasma MilanziJeanette C. Reece Colorectal Cancer 26 November 2019 Pages: 1570 - 1579
The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival Nelleke P. M. BrouwerDave E. W. van der KruijssenJohannes H. W. de Wilt Colorectal Cancer Open access 02 December 2019 Pages: 1580 - 1588
Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer Glauco BaiocchiHenrique MantoanLouise De Brot Gynecologic Oncology 04 November 2019 Pages: 1589 - 1594
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia Bofeng ChenMaxwell T. TrudeauCharles M. Vollmer Jr. Pancreatic Tumors 05 November 2019 Pages: 1595 - 1605
Main Pancreatic Duct to Parenchymal Thickness Ratio at Preoperative Imaging is Associated with Overall Survival in Upfront Resected Pancreatic Cancer Marta SandiniAdrian A. Negreros-OsunaCarlos Fernández-del Castillo Pancreatic Tumors 13 November 2019 Pages: 1606 - 1612
The ‘TRIANGLE Operation’ by Laparoscopy: Radical Pancreaticoduodenectomy with Major Vascular Resection for Borderline Resectable Pancreatic Head Cancer Edoardo RossoGiuseppe ZimmittiMarco Garatti Pancreatic Tumors 04 December 2019 Pages: 1613 - 1614
ASO Author Reflections: Mini-invasive Pancreaticoduodenectomy—Moving from Feasible to Radical Edoardo RossoAntonio Iannelli ASO Author Reflections 09 March 2020 Pages: 1615 - 1616
Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients Andrea V. BarrioStephanie Downs-CannerMonica Morrow Breast Oncology 09 December 2019 Pages: 1617 - 1624